Advanced liver fibrosis and the metabolic syndrome in a primary care setting

Author(s):  
Andrew D. Schreiner ◽  
Jingwen Zhang ◽  
Valerie Durkalski‐Mauldin ◽  
Sherry Livingston ◽  
Justin Marsden ◽  
...  
2011 ◽  
Vol 64 (10) ◽  
pp. 916-920 ◽  
Author(s):  
C Rinaldi A Lesmana ◽  
Simon Salim ◽  
Irsan Hasan ◽  
Andri S Sulaiman ◽  
Rino A Gani ◽  
...  

BackgroundA non-invasive method to assess liver fibrosis by measuring liver stiffness with transient elastography (TE) has been recently introduced. The role of TE among chronic hepatitis B (CHB) patients in starting antiviral therapy in the primary care setting is still controversial because of its high cost. The AST to platelet ratio index (APRI) could be a much cheaper alternative.ObjectivesThis study compares the diagnostic accuracy of TE and APRI in assessing liver fibrosis in CHB patients.Patients and MethodsA cross-sectional study in CHB patients intending to start antiviral treatment. Liver fibrosis was staged according to the METAVIR scoring system. Liver stiffness was measured by TE performed on the same day with liver biopsy, while APRI was calculated as follows: APRI=(AST/upper limit of normal)×100/platelet count (109/l). Cutoff levels of liver stiffness and APRI were calculated by using the receiver operating characteristic curve to detect significant liver fibrosis, defined as fibrosis stage F2 or more.Results117 patients were enrolled in the study; their mean age was 40.6±10.97 years. The median liver stiffness was 5.9 kPa (2.5–48 kPa) and the median APRI was 0.239 (0.09–2.73). The cutoff level of liver stiffness was 5.85 kPa for ≥F2 with an AUC of 0.614, 60.3% sensitivity, 63.6% specificity, 73.3% PPV, 49.1% NPV and a LR+ of 1.66. The APRI cutoff level was 0.235 for F≥2 with an AUC of 0.693, 64.4% sensitivity, 70.5% specificity, 78.3% PPV, 54.4% NPV and a LR+ of 2.18. Both methods gave comparable diagnostic accuracy.ConclusionAPRI is a useful marker to screen liver fibrosis in the primary care setting when TE is not available.


2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
M. Demede ◽  
A. Pandey ◽  
F. Zizi ◽  
R. Bachmann ◽  
M. Donat ◽  
...  

We ascertained the prevalence of resistant hypertension (RH) among blacks and determined whether RH patients are at greater risk for obstructive sleep apnea (OSA) than hypertensives.Method. Data emanated from Metabolic Syndrome Outcome Study (MetSO), a study investigating metabolic syndrome among blacks in the primary-care setting. Sample of 200 patients (mean age = 63 ± 13 years; female = 61%) with a diagnosis of hypertension provided subjective and clinical data. RH was defined using the JNC 7and European Society guidelines. We assessed OSA risk using the Apnea Risk Evaluation System ARES), defining high risk as a total ARES score ≥6.Results. Overall, 26% met criteria for RH and 40% were at high OSA risk. Logistic regression analysis, adjusting for effects of age, gender, and medical co morbidities, showed that patients with RH were nearly 2.5 times more likely to be at high OSA risk, relative to those with hypertension (OR = 2.46, 95% CI: 1.03–5.88,P<.05).Conclusion. Our findings show that the prevalence of RH among blacks fell within the range of RH for the general hypertensive population (3–29%). However, patients with RH were at significantly greater risk of OSA compared to patients with hypertension.


2008 ◽  
Vol 11 (Suppl 1) ◽  
pp. P137
Author(s):  
F Blanco ◽  
P Barreiro ◽  
P Ryan ◽  
E Vispo ◽  
L Martin-Carbonero ◽  
...  

2012 ◽  
Vol 20 ◽  
pp. S159-S160
Author(s):  
C. Orellana ◽  
N. Navarro ◽  
J. Calvet ◽  
M. García-Manrique ◽  
J. Gratacós ◽  
...  

2011 ◽  
Vol 29 ◽  
pp. e299-e300
Author(s):  
F. Valls-Roca ◽  
V. Pallares-Carratala ◽  
V. Gil-Guillen ◽  
D. Orozco-Beltran ◽  
J. L. Llisterri-Caro ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 494-495 ◽  
Author(s):  
Michael Naslund ◽  
Alicia Gilsenan ◽  
Kirk Midkiff ◽  
Eric Wolford ◽  
Aileen Bown ◽  
...  

2008 ◽  
Author(s):  
Ruth Elaine Graves ◽  
Tanya N. Alim ◽  
Notalelomwan Aigbogun ◽  
Thomas A. Mellman ◽  
William B. Lawson

Sign in / Sign up

Export Citation Format

Share Document